


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+13.77%
-2.28%
-14.01%
-12.17%
ATRC
AtriCure
$31.26
Strengths

Earnings are forecast to grow
ATRC Price Performance
$36.82 (-15.10%)
$36.31 (-13.91%)
$34.73 (-9.99%)
$33.78 (-7.46%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Earnings decline YoY
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
ATRC Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ATRC Street Sentiment is bullish and have positive views on the near-term outlook
ATRC has Low risk level
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Dec 17, 2025
Reiterate
Overweight
JP Morgan
Oct 31, 2025
Reiterate
Buy
Canaccord Genuity
What is ATRC current stock price?
What are ATRC stock strengths?
What is ATRC Risk Level?
What is ATRC market cap and volume?
What is ATRC current Stock IQ?
Should I buy ATRC stock right now?
Is ATRC a Strong Buy right now?
What does a 'Strong Buy' rating mean for ATRC?
What does a 'Strong Sell' rating mean for ATRC?
What factors influence ATRC's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
ATRC
AtriCure
Current Price
$31.26

ATRC Price Performance
$36.82 (-15.10%)
$36.31 (-13.91%)
$34.73 (-9.99%)
$33.78 (-7.46%)
ATRC Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Earnings decline YoY
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
ATRC Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ATRC Street Sentiment is bullish and have positive views on the near-term outlook
ATRC has Low risk level
Average key support and resistance price levels
Overall Wall Street Rating
ATRC Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow
ATRC Latest Analysis
Oversold Conditions For AtriCure (ATRC). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me
Wed Feb 25, 2026
AtriCure Delivers 15% Revenue Growth In FY25 Projects 12-14% Growth In FY26 . (RTTNews) - AtriCure Inc. (ATRC) a medical instrument manufacturer announced fourth-quarter and full-year 2025 financial results and provided rosy guidance for 2026. Following the news ATRC shares are up 6.16% at $35.00.
Wed Feb 18, 2026
AtriCure targets 12%-14% revenue growth in 2026 as innovation and clinical progress drive momentum.
Tue Feb 17, 2026
AtriCure Non-GAAP EPS of $0.06 beats by $0.10 revenue of $140.5M beats by $0.72M.
Tue Feb 17, 2026
ATRC Makes Notable Cross Below Critical Moving Average. In trading on Wednesday shares of AtriCure Inc (Symbol: ATRC) crossed below their 200 day moving average of $35.30 changing hands as low as $30.47 per share. AtriCure Inc shares are currently trading off about 15.4% on the day. The chart below shows the one year performance
Wed Feb 11, 2026
Will AtriCure (ATRC) Report Negative Earnings Next Week? What You Should Know. AtriCure (ATRC) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tue Feb 10, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ATRC Stock trends
ATRC Stock performance
ATRC Stock analysis
ATRC investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.